| Mitoxantrone |
ІІ-10773/04.05.2005 г. |
MITOXANTRON "EBEWE", Concentrate for solution for infusion, 2 mg/ml - 5 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
45.86 |
9.17 |
55.03 |
4% |
1.83 |
47.69 |
9.54 |
57.23 |
16% |
7.34 |
55.03 |
11.01 |
66.04 |
Цената се заличава с решение НСР-3012/12.03.2014 |
НСР-1987/06.12.2013 |
24.12.2013 |
24.12.2013 |
Заличен |
2339 |
| Mitoxantrone |
ІІ-10773/04.05.2005 г. |
MITOXANTRON "EBEWE", Concentrate for solution for infusion, 2 mg/ml - 10 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
50.09 |
10.02 |
60.11 |
4% |
2 |
52.09 |
10.42 |
62.51 |
16% |
8.01 |
60.1 |
12.02 |
72.12 |
|
НСР-1986/06.12.2013 |
24.12.2013 |
24.12.2013 |
Активен |
2338 |
| Mitoxantrone |
ІІ-10773/04.05.2005 г. |
MITOXANTRON "EBEWE", Concentrate for solution for infusion, 2 mg/ml - 10 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
174.32 |
34.86 |
209.18 |
4% |
6.97 |
181.29 |
36.26 |
217.55 |
16% |
25 |
206.29 |
41.26 |
247.55 |
|
КЦ-1296/21.01.2010 |
07.02.2010 |
07.02.2010 |
Неактивен |
2338 |
| Mitoxantrone |
ІІ-10773/04.05.2005 г. |
MITOXANTRON "EBEWE", Concentrate for solution for infusion, 2 mg/ml - 5 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
97.62 |
19.52 |
117.14 |
4% |
3.9 |
101.52 |
20.3 |
121.82 |
16% |
15.62 |
117.14 |
23.43 |
140.57 |
|
КЦ-1296/21.01.2010 |
07.02.2010 |
07.02.2010 |
Неактивен |
2339 |
| Indapamide |
20080049 |
Mivara SR, Prolonged release tablet, 1.5, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Stada Arzneimittel AG, Германия, Centrafarm Services, Netherlands, Stada Production Ireland, Ireland |
2.78 |
0.56 |
3.34 |
7% |
0.19 |
2.97 |
0.59 |
3.56 |
20% |
0.56 |
3.53 |
0.71 |
4.24 |
|
КЦРР-2180/06.02.2013 г |
25.02.2013 |
25.02.2013 |
Активен |
1629 |
| Indapamide |
2419/04,07,2008 |
Mivara SR, Prolonged release tablet, 1.5, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Stada Arneimittel AG, Germany; Centrafarm Services B.v. - The Netherland; Stada Production Ireland Ltd. - Ireland |
3.72 |
0.74 |
4.46 |
7% |
0.26 |
3.98 |
0.8 |
4.78 |
20% |
0.74 |
4.72 |
0.94 |
5.66 |
|
КЦРР-787/15.06.2012 |
02.07.2012 |
02.07.2012 |
Неактивен |
1629 |
| Indapamide |
2419/04,07,2008 |
Mivara SR, Prolonged release tablet, 1.5, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Stada Arneimittel AG, Germany; Centrafarm Services B.v. - The Netherland; Stada Production Ireland Ltd. - Ireland |
4.11 |
0.82 |
4.93 |
9% |
0.37 |
4.48 |
0.9 |
5.38 |
22% |
0.9 |
5.38 |
1.08 |
6.46 |
корекц. КЦ-778/07.04.2009 |
КЦ-759/31.03.2009 |
18.04.2009 |
18.04.2009 |
Неактивен |
1629 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
39.53 |
7.91 |
47.44 |
4% |
1.58 |
41.11 |
8.22 |
49.33 |
16% |
6.32 |
47.43 |
9.49 |
56.92 |
|
НСР-6606/01.07.2015 |
17.07.2015 |
17.07.2015 |
Активен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
39.53 |
7.91 |
47.44 |
4% |
1.58 |
41.11 |
8.22 |
49.33 |
16% |
6.32 |
47.43 |
9.49 |
56.92 |
|
НСР-6606/01.07.2015 |
17.07.2015 |
17.07.2015 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
39.94 |
7.99 |
47.93 |
4% |
1.6 |
41.54 |
8.31 |
49.85 |
16% |
6.39 |
47.93 |
9.59 |
57.52 |
|
НСР-3423/30.04.2014 |
22.05.2014 |
22.05.2014 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
40.8 |
8.16 |
48.96 |
4% |
1.63 |
42.43 |
8.49 |
50.92 |
16% |
6.53 |
48.96 |
9.79 |
58.75 |
|
НСР-1035/23.08.2013 |
17.09.2013 |
17.09.2013 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé DK-2880 Bagsværd, Дания; Novo Nordisk Production SAS 45, Avenue d’Orléans F-28002 Chartres, Франция |
40.82 |
8.16 |
48.98 |
4% |
1.63 |
42.45 |
8.49 |
50.94 |
16% |
6.53 |
48.98 |
9.8 |
58.78 |
корекц. решение КЦРР-1762/04.12.2012 |
КЦРР-1341/24.08.2012 |
12.12.2012 |
12.12.2012 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
1)Novo Nordisk A/S Novo Allé DK-2880 Bagsværd, Дания 2)Novo Nordisk Production SAS 45, Avenue d’Orléans F-28002 Chartres, Франция |
41.74 |
8.35 |
50.09 |
4% |
1.67 |
43.41 |
8.68 |
52.09 |
16% |
6.68 |
50.09 |
10.02 |
60.11 |
|
КЦ-730/18.03.2009 |
02.04.2009 |
02.04.2009 |
Неактивен |
2777 |
| Measles, mumps and rubella vaccine (live) |
EU/1/06/337/011 |
M-M-RVAXPRO, Powder and solvent for suspension for injection, 0,5 ml, -, Pack: 1 vial + 1 pre-filled syringe + 2 needles |
Sanofi Pasteur MSD, SNC, Франция |
Merck Sharp & Dohme B.V., Холандия |
14.96 |
2.99 |
17.95 |
6% |
0.9 |
15.86 |
3.17 |
19.03 |
18% |
2.69 |
18.55 |
3.71 |
22.26 |
|
НСР-2854/21.02.2014 |
07.03.2014 |
07.03.2014 |
Активен |
2517 |
| Moclobemide |
II-3497/13,11,2008 |
Moclobemide Sopharma, Film coated tablet, 150, mg, Pack: 30 |
Софарма АД, България |
СОФАРМА АД |
8.24 |
1.65 |
9.89 |
9% |
0.74 |
8.98 |
1.8 |
10.78 |
22% |
1.81 |
10.79 |
2.16 |
12.95 |
цената се заличава КЦРР-900/28.06.2012 |
КЦ-879/12.05.2009 |
29.05.2009 |
29.05.2009 |
Заличен |
726 |
| Fluphenazine |
II-12995/17.05.2006 |
MODITEN DEPO solution for injection 25 mg/ml x 5, Solution for injection, 25, mg/ml, Pack: 5 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Slovenia |
13.06 |
2.61 |
15.67 |
6% |
0.78 |
13.84 |
2.77 |
16.61 |
18% |
2.35 |
16.19 |
3.24 |
19.43 |
|
КЦ-412/07.01.2009 |
02.02.2009 |
02.02.2009 |
Активен |
440 |
| Trimetazidine |
20110539 |
Moduxin MR, Prolonged release tablet, 35, mg, Pack: 60 |
Gedeon Richter Plc., Унгария |
Gedeon Richter Plc., Hungary |
8.19 |
1.64 |
9.83 |
7% |
0.57 |
8.76 |
1.75 |
10.51 |
20% |
1.64 |
10.4 |
2.08 |
12.48 |
|
НСР-6679/09.07.2015 |
25.07.2015 |
25.07.2015 |
Активен |
2724 |
| Trimetazidine |
20110539 |
Moduxin MR, Prolonged release tablet, 35, mg, Pack: 60 |
Gedeon Richter Plc., Унгария |
Gedeon Richter Plc., Hungary |
8.68 |
1.74 |
10.42 |
7% |
0.61 |
9.29 |
1.86 |
11.15 |
20% |
1.74 |
11.03 |
2.21 |
13.24 |
|
НСР-3310/24.04.2014 |
08.05.2014 |
08.05.2014 |
Неактивен |
2724 |
| Trimetazidine |
20110539 |
Moduxin MR, Prolonged release tablet, 35, mg, Pack: 60 |
Gedeon Richter Plc., Унгария |
Gedeon Richter Plc., Hungary |
8.82 |
1.76 |
10.58 |
7% |
0.62 |
9.44 |
1.89 |
11.33 |
20% |
1.76 |
11.2 |
2.24 |
13.44 |
|
НСР-644/29.07.2013 |
26.08.2013 |
26.08.2013 |
Неактивен |
2724 |
| Trimetazidine |
20110539 |
Moduxin MR, Prolonged release tablet, 35, mg, Pack: 60 |
Gedeon Richter Plc., Унгария |
Gedeon Richter Plc., Hungary |
10.37 |
2.07 |
12.44 |
6% |
0.62 |
10.99 |
2.2 |
13.19 |
18% |
1.87 |
12.86 |
2.57 |
15.43 |
|
КЦРР-1572/05.11.2012 |
22.11.2012 |
22.11.2012 |
Неактивен |
2724 |
| Moexipril |
II-1320/21.12.2007 |
Moex, Film coated tablet, 15, mg, Pack: 30 |
UCB Pharma GmbH, Германия |
AESICA Pharmaceuticals GmbH, Германия |
13.32 |
2.66 |
15.98 |
6% |
0.8 |
14.12 |
2.82 |
16.94 |
18% |
2.4 |
16.52 |
3.3 |
19.82 |
промяна на обстоятелства НСР-6249/21.05.2015 |
КЦРР-1126/02.08.2012 |
14.09.2012 |
14.09.2012 |
Активен |
1348 |
| Moexipril |
II-1320/21.12.2007 |
Moex, Film coated tablet, 15, mg, Pack: 30 |
Schwarz Pharma AG, Германия |
Schwarz Pharma AG, Germany |
13.98 |
2.8 |
16.78 |
6% |
0.84 |
14.82 |
2.96 |
17.78 |
18% |
2.52 |
17.34 |
3.47 |
20.81 |
|
КЦ-520/09.02.2009 |
02.03.2009 |
02.03.2009 |
Неактивен |
1348 |
| Moexipril |
II-1319/21.12.2007 |
Moex, Film coated tablet, 7.5, mg, Pack: 30 |
UCB Pharma GmbH, Германия |
AESICA Pharmaceuticals GmbH, Германия |
7 |
1.4 |
8.4 |
7% |
0.49 |
7.49 |
1.5 |
8.99 |
20% |
1.4 |
8.89 |
1.78 |
10.67 |
промяна на обстоятелства НСР-6248/21.05.2015 |
КЦ-520/09.02.2009 |
02.03.2009 |
02.03.2009 |
Активен |
509 |
| Molsidomine |
20040225 |
Molsidomin WZF, Tablet, 2, mg, Pack: 30 |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
Warsaw Pharmaceutical Works Polfa S.A., Полша |
1.94 |
0.39 |
2.33 |
7% |
0.14 |
2.08 |
0.42 |
2.5 |
20% |
0.39 |
2.47 |
0.49 |
2.96 |
|
НСР-2907/05.03.2014 |
20.03.2014 |
20.03.2014 |
Активен |
2561 |
| Montelukast |
II-23071/31.07.2013 |
Monkasta, Chewable tablet, 4, mg, Pack: 28 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Slovenia; KRKA Polska Sp.z.o., ul Rownolegla 5, Warszawa, Полша; TAD Pharma GmbH, Германия |
6.92 |
1.38 |
8.3 |
7% |
0.48 |
7.4 |
1.48 |
8.88 |
20% |
1.38 |
8.78 |
1.76 |
10.54 |
промяна на обстоятелства НСР-6297/28.05.2015 ; Цената е вписана в регистъра на пределните цени с решение НСР-6298/28.05.2015 ( в сила от 16.06.2015) |
НСР-3060/21.03.2014 |
08.04.2014 |
08.04.2014 |
Заличен |
2641 |